Instituto Nacional de Pediatría

Coyoacán 4530

0 studies enrolling now · 2 studies all time

What they study most

Diabetes Mellitus, Type 2, Respiratory Syncytial Virus Infections

Studies at this site

• A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus — Completed
• Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection — Stopped early